BluMaiden Biosciences, in collaboration with AWS, offers a comprehensive Pharma Services platform that addresses the challenges of generating clinical trial information. The platform ensures secure data processing and compliance with industry standards such as HIPAA and GDPR. By leveraging advanced analytics and predictive modeling, the platform helps in patient enrichment, stratification, and optimizing clinical outcomes, leading to increased efficiency and profitability.
The architectural design of the platform focuses on accurate data annotation and curation, ensuring meaningful insights from clinical studies. The platform utilizes Amazon S3 for data storage and retrieval and leverages AWS Batch service and Amazon EC2 Spot instances to optimize costs and achieve faster data analytics. BluMaiden benefits from resilient systems and seamless global data sharing through Amazon S3 Data Lake and Amazon Aurora database.
BluMaiden’s Pharma Services platform delivers significant value propositions by unlocking deep clinical insights from vast data repositories, driving informed decision-making and optimizing trial outcomes. The platform offers new clinical insights applicable across all trial cohorts and prioritizes regulatory compliance and data security. In partnership with AWS, BluMaiden aims to shape the future of clinical research with innovative solutions and clear clinical utility for pharmaceutical stakeholders.
As an AWS Advanced Technology Partner and AWS Competency Partner, BluMaiden stands out as a data-driven innovator providing actionable clinical insights for improving decision-making in clinical trials. With a focus on security, compliance, and value creation, BluMaiden’s partnership with AWS brings cutting-edge solutions to the pharmaceutical industry.
Article Source
https://aws.amazon.com/blogs/apn/guiding-clinical-trial-decision-making-with-reliable-clinical-insights-how-blumaiden-biosciences-brings-its-pharma-service-to-global-clients-through-aws/